As of 2025-02-13, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is (0.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.94 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is -131.3%.
The range of the Relative Valuation is (0.60) - (0.61) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 38.8x - 46.5x | 42.6x |
Forward P/E multiples | 32.4x - 39.9x | 36.2x |
Fair Price | (0.60) - (0.61) | (0.61) |
Upside | -130.8% - -131.7% | -131.3% |
Date | P/E |
2025-02-07 | -110.46 |
2025-02-06 | -126.05 |
2025-02-05 | -137.09 |
2025-02-04 | -141.64 |
2025-02-03 | -136.12 |
2025-01-31 | -152.04 |
2025-01-30 | -149.44 |
2025-01-29 | -241.70 |
2025-01-28 | -246.90 |
2025-01-27 | -246.90 |
2025-01-24 | -241.05 |
2025-01-23 | -244.95 |
2025-01-22 | -241.70 |
2025-01-21 | -246.25 |
2025-01-17 | -237.80 |
2025-01-16 | -245.60 |
2025-01-15 | -243.00 |
2025-01-14 | -237.15 |
2025-01-13 | -244.95 |
2025-01-10 | -257.30 |
2025-01-08 | -297.58 |
2025-01-07 | -294.33 |
2025-01-06 | -292.38 |
2025-01-03 | -293.03 |
2025-01-02 | -281.34 |
2024-12-31 | -287.83 |
2024-12-30 | -284.58 |
2024-12-27 | -289.13 |
2024-12-26 | -298.23 |
2024-12-24 | -299.53 |
2024-12-23 | -298.23 |
2024-12-20 | -289.13 |
2024-12-19 | -252.10 |
2024-12-18 | -224.81 |
2024-12-17 | -229.36 |
2024-12-16 | -224.16 |
2024-12-13 | -229.36 |
2024-12-12 | -231.31 |
2024-12-11 | -239.75 |
2024-12-10 | -241.70 |
2024-12-09 | -258.59 |
2024-12-06 | -222.86 |
2024-12-05 | -217.01 |
2024-12-04 | -230.66 |
2024-12-03 | -230.01 |
2024-12-02 | -235.20 |
2024-11-29 | -228.71 |
2024-11-27 | -238.45 |
2024-11-26 | -228.71 |
2024-11-25 | -217.66 |